261 related articles for article (PubMed ID: 35654979)
1. Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates.
Brown KM; Nair JK; Janas MM; Anglero-Rodriguez YI; Dang LTH; Peng H; Theile CS; Castellanos-Rizaldos E; Brown C; Foster D; Kurz J; Allen J; Maganti R; Li J; Matsuda S; Stricos M; Chickering T; Jung M; Wassarman K; Rollins J; Woods L; Kelin A; Guenther DC; Mobley MW; Petrulis J; McDougall R; Racie T; Bombardier J; Cha D; Agarwal S; Johnson L; Jiang Y; Lentini S; Gilbert J; Nguyen T; Chigas S; LeBlanc S; Poreci U; Kasper A; Rogers AB; Chong S; Davis W; Sutherland JE; Castoreno A; Milstein S; Schlegel MK; Zlatev I; Charisse K; Keating M; Manoharan M; Fitzgerald K; Wu JT; Maier MA; Jadhav V
Nat Biotechnol; 2022 Oct; 40(10):1500-1508. PubMed ID: 35654979
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated gene silencing in non-human primates.
Zimmermann TS; Lee AC; Akinc A; Bramlage B; Bumcrot D; Fedoruk MN; Harborth J; Heyes JA; Jeffs LB; John M; Judge AD; Lam K; McClintock K; Nechev LV; Palmer LR; Racie T; Röhl I; Seiffert S; Shanmugam S; Sood V; Soutschek J; Toudjarska I; Wheat AJ; Yaworski E; Zedalis W; Koteliansky V; Manoharan M; Vornlocher HP; MacLachlan I
Nature; 2006 May; 441(7089):111-4. PubMed ID: 16565705
[TBL] [Abstract][Full Text] [Related]
3. Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles.
Sugo T; Terada M; Oikawa T; Miyata K; Nishimura S; Kenjo E; Ogasawara-Shimizu M; Makita Y; Imaichi S; Murata S; Otake K; Kikuchi K; Teratani M; Masuda Y; Kamei T; Takagahara S; Ikeda S; Ohtaki T; Matsumoto H
J Control Release; 2016 Sep; 237():1-13. PubMed ID: 27369865
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates.
Frank-Kamenetsky M; Grefhorst A; Anderson NN; Racie TS; Bramlage B; Akinc A; Butler D; Charisse K; Dorkin R; Fan Y; Gamba-Vitalo C; Hadwiger P; Jayaraman M; John M; Jayaprakash KN; Maier M; Nechev L; Rajeev KG; Read T; Röhl I; Soutschek J; Tan P; Wong J; Wang G; Zimmermann T; de Fougerolles A; Vornlocher HP; Langer R; Anderson DG; Manoharan M; Koteliansky V; Horton JD; Fitzgerald K
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11915-20. PubMed ID: 18695239
[TBL] [Abstract][Full Text] [Related]
5. In vivo self-assembled small RNAs as a new generation of RNAi therapeutics.
Fu Z; Zhang X; Zhou X; Ur-Rehman U; Yu M; Liang H; Guo H; Guo X; Kong Y; Su Y; Ye Y; Hu X; Cheng W; Wu J; Wang Y; Gu Y; Lu SF; Wu D; Zen K; Li J; Yan C; Zhang CY; Chen X
Cell Res; 2021 Jun; 31(6):631-648. PubMed ID: 33782530
[TBL] [Abstract][Full Text] [Related]
6. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
Traber GM; Yu AM
J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
[TBL] [Abstract][Full Text] [Related]
7. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
[TBL] [Abstract][Full Text] [Related]
8. A novel siRNA validation system for functional screening and identification of effective RNAi probes in mammalian cells.
Hung CF; Lu KC; Cheng TL; Wu RH; Huang LY; Teng CF; Chang WT
Biochem Biophys Res Commun; 2006 Aug; 346(3):707-20. PubMed ID: 16793020
[TBL] [Abstract][Full Text] [Related]
9. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R
Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435
[TBL] [Abstract][Full Text] [Related]
10. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
11. RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges.
Won Lee J; Kyu Shim M; Kim H; Jang H; Lee Y; Hwa Kim S
Adv Drug Deliv Rev; 2023 Oct; 201():115073. PubMed ID: 37657644
[TBL] [Abstract][Full Text] [Related]
12. Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury.
Marinho HS; Marcelino P; Soares H; Corvo ML
Curr Pharm Des; 2018; 24(23):2692-2700. PubMed ID: 30084326
[TBL] [Abstract][Full Text] [Related]
13. Centyrin ligands for extrahepatic delivery of siRNA.
Klein D; Goldberg S; Theile CS; Dambra R; Haskell K; Kuhar E; Lin T; Parmar R; Manoharan M; Richter M; Wu M; Mendrola Zarazowski J; Jadhav V; Maier MA; Sepp-Lorenzino L; O'Neil K; Dudkin V
Mol Ther; 2021 Jun; 29(6):2053-2066. PubMed ID: 33601052
[TBL] [Abstract][Full Text] [Related]
14. In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
ElHefnawi M; Kim T; Kamar MA; Min S; Hassan NM; El-Ahwany E; Kim H; Zada S; Amer M; Windisch MP
PLoS One; 2016; 11(7):e0159211. PubMed ID: 27441640
[TBL] [Abstract][Full Text] [Related]
15. Preparation, Determination of Activity, and Biodistribution of Cholesterol-Containing Nuclease-Resistant siRNAs In Vivo.
Chernikov IV; Meschaninova MI; Chernolovskaya EL
Methods Mol Biol; 2020; 2115():57-77. PubMed ID: 32006394
[TBL] [Abstract][Full Text] [Related]
16. Development of Prodrug Type Circular siRNA for
Hagiwara K; Honma M; Harumoto T; Harada K; Sawada T; Yamamoto J; Shinohara F
Nucleic Acid Ther; 2020 Dec; 30(6):346-364. PubMed ID: 33016851
[TBL] [Abstract][Full Text] [Related]
17. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
18. The Growing Class of Novel RNAi Therapeutics.
Traber GM; Yu AM
Mol Pharmacol; 2024 Jun; 106(1):13-20. PubMed ID: 38719476
[TBL] [Abstract][Full Text] [Related]
19. siRNA Therapeutics in Ocular Diseases.
Moreno-Montañés J; Bleau AM; Martínez T; Vargas B; González MV; Jiménez AI
Methods Mol Biol; 2021; 2282():417-442. PubMed ID: 33928588
[TBL] [Abstract][Full Text] [Related]
20. A combinatorial approach for achieving CNS-selective RNAi.
Ferguson CM; Godinho BMDC; Echeverria D; Hassler M; Vangjeli L; Sousa J; McHugh N; Alterman J; Hariharan V; Krishnamurthy PM; Watts J; Rogaev E; Khvorova A
Nucleic Acids Res; 2024 May; 52(9):5273-5284. PubMed ID: 38348876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
